Your session is about to expire
← Back to Search
N/A
Ultrasound-Guided Biopsy for Breast Cancer
N/A
Waitlist Available
Led By Henry Kuerer, MD, PHD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Study Summary
This trial will compare using ultrasound to guide a biopsy needle to what is found during surgery, in order to see how well ultrasound works in finding evidence of the disease.
Who is the study for?
This trial is for adults over 18 with a specific type of breast cancer (either triple negative or HER2 amplified) at various stages. Participants are those who have received preoperative therapy and are planning to undergo surgery.Check my eligibility
What is being tested?
The study is examining the effectiveness of using ultrasound-guided biopsy to detect breast cancer compared to traditional surgical methods. It aims to see if this less invasive technique can reliably find evidence of disease.See study design
What are the potential side effects?
Since the intervention being studied is an ultrasound-guided biopsy, potential side effects may include discomfort, bruising, bleeding at the biopsy site, and very rarely infection.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Diagnostic Accuracy of Ultrasound-Guided FNA and Core Biopsy of Initial Breast Cancer Region Compared to Standard Surgery with Pathologic Evaluation
Trial Design
1Treatment groups
Experimental Treatment
Group I: Ultrasound-Guided Biopsy of Tumor SiteExperimental Treatment1 Intervention
Ultrasound-guided biopsy of the tumor site performed before scheduled surgery.
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,971 Previous Clinical Trials
1,787,194 Total Patients Enrolled
147 Trials studying Breast Cancer
63,243 Patients Enrolled for Breast Cancer
Henry Kuerer, MD, PHDPrincipal InvestigatorM.D. Anderson Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- This criterion is not applicable.You have a specific type of breast cancer and are currently getting treatment before surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Ultrasound-Guided Biopsy of Tumor Site
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there opportunities for participation in this research endeavor?
"This trial, which was opened on June 24th 2015 and last edited February 23rd 2022, is not currently enrolling patients. Nevertheless, there are presently 2603 other medical studies actively recruiting participants."
Answered by AI
Share this study with friends
Copy Link
Messenger